Intellia Therapeutics Inc
NASDAQ: NTLA
$8.20
+$0.02 (+0.2%)
Real Time Data Delayed 15 Min.
NTLA Stock Chart and Intraday Price
NTLA Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Address | 40 ERIE STREET, SUITE 130, CAMBRIDGE, MA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 3,138.84M USD |
| Shares Outstanding | 96,106,000 |
NTLA Articles
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Published:
Wednesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Asana, Charles Schwab, Estee Lauder, General Electric, GitLab, Home Depot, Match, Ovintiv, SoFi Technologies and...
Published:
Last Updated:
Wednesday's top analyst upgrades and downgrades included Amazon.com, Blackstone, Caesars Entertainment, Dollar Tree, DraftKings, GlobalFoundries, IBM, Lyft, Marathon Oil, McDonald's, Palo Alto...
Published:
Thursday’s top analyst upgrades and downgrades included AutoZone, CrowdStrike, Estee Lauder, Morgan Stanley, Nvidia and Western Digital.
Published:
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information Services, FedEx, NexTier...
Published:
Tuesday's top analyst upgrades and downgrades included Apple, Continental Resources, Bilibili, Eaton, Hershey, Meta Platforms, Nio, NOV, PayPal and Southern Company.
Published:
Last Updated:
Friday afternoon's analyst upgrades and downgrades included Barrick Gold, Canadian National Railway, Community Health Systems, Editas Medicine, Intellia Therapeutics, Newmont and Salesforce.com.
Published:
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
Friday's top analyst upgrades and downgrades included Biogen, CME, Dropbox, DocuSign, Nvidia, Ping Identity, Signet Jewelers and Tilray.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Etsy, Fate Therapeutics, Intellia, Ionis, Monster Beverage and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Domino’s Pizza, Editas Medicine, Roblox, Teva Pharmaceutical Industries and U.S. Steel.
Published:
